banner ad

Recent Articles

Neuromodulator Threading Revisiting an Approach to Neurotoxin Delivery

| June 23, 2014 | 0 Comments

H. William Higgins II, MD, MBE; Kachiu C. Lee, MD, MPH; Yoash Enzer, MD Department of Dermatology, Brown University, Providence, Rhode Island; Department of Surgery (Ophthalmology), Brown University, Providence Rhode Island Disclosure: The authors report no relevant conflicts of interest. Abstract Neuromodulator toxins are traditionally delivered to facial muscles via a depot technique using a […]

Continue Reading

Fulminans in Dermatology: A Call to Action A Recommendation for Consideration of the Term Scleredema Fulminans

| June 23, 2014 | 0 Comments

Lacy L. Sommer, MD; Warren R. Heymann, MD Division of Dermatology, Cooper Medical School of Rowan University, Camden, New Jersey Disclosure: The authors report no relevant conflicts of interest. Abstract The term fulminans is used infrequently in dermatology, being reserved for those cases of rapid onset with potentially severe sequelae or those that are life-threatening, […]

Continue Reading

Injection Therapy for the Management of Superficial Subcutaneous Lipomas

| June 23, 2014 | 0 Comments

Kyle T. Amber, MD; Steven Ovadia, MD; Ivan Camacho, MD University of Miami, Department of Dermatology and Cutaneous Surgery, Miami, Florida Disclosure: The authors report no relevant conflicts of interest. Abstract Superficial subcutaneous lipomas are common benign tumors of the subcutaneous adipose tissue. Removal of superficial subcutaneous lipomas is achieved with simple surgical excision for […]

Continue Reading

Efficacy and Safety of a Low Molecular Weight Hyaluronic Acid Topical Gel in the Treatment of Facial Seborrheic Dermatitis Final Report

| May 20, 2014 | 0 Comments

Todd Schlesinger, MD, FAAD; Callie Rowland Powell, BSN, RN Dermatology and Laser Center of Charleston, Clinical Research Department, Charleston, South Carolina Abstract Objective: Hyaluronic acid sodium salt gel 0.2% is a topical device effective in reducing skin inflammation. Facial seborrheic dermatitis, characterized by erythema and or flaking/scaling in areas of high sebaceous activity, affects up […]

Continue Reading

Double-blind, Placebo-controlled Study Assessing the Effect of Chocolate Consumption in Subjects with a History of Acne Vulgaris

| May 20, 2014 | 0 Comments

Caroline Caperton, MD, MSPH; Samantha Block, BS; Martha Viera, MD; Jonette Keri, MD, PhD; Brian Berman, MD, PhD University of Miami, Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, Florida; Skin & Cancer Associates, LLP; Co-Director Center for Clinical and Cosmetic Research, Aventura, Florida Abstract Objective: To assess the effect of chocolate […]

Continue Reading

Race, Rather than Skin Pigmentation, Predicts Facial Hair Growth in Women

| May 20, 2014 | 0 Comments

Emilia Javorsky, MPH; Alexis C. Perkins, MD; Greg Hillebrand, PhD; Kukizo Miyamoto, PhD; Alexa Boer Kimball, MD, MPH University of Massachusetts Medical School, Worcester, Massachusetts; Dermatology Associates of Concord, Concord, Massachusetts; Procter & Gamble, Cincinnati, Ohio; Procter & Gamble, Kobe, Japan; Department of Dermatology, Harvard University School of Medicine, Boston, Massachusetts Abstract Background: The Ferriman-Gallwey […]

Continue Reading

Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation

| May 20, 2014 | 0 Comments

James H. Herndon Jr., MD, FAAD; Elizabeth T. Makino, BS, CCRA, MBA; Thomas J. Stephens, PhD; Rahul C. Mehta, PhD Thomas J. Stephens & Associates, Carrollton, Texas; SkinMedica Inc., an Allergan Company, Carlsbad, California Abstract Objective: To evaluate the efficacy and tolerability of a multimodal skin-brightening regimen in subjects with facial hyperpigmentation. Design: Open-label, single-center […]

Continue Reading